Article PDF
References
Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? (Editorial). Can J Anesth 2007; 54: 689–95.
de Boer HD, van Egmond J, van de Pol F, Bom A, Driessen JJ, Booij LH. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation. Br J Anaesth 2006; 97: 681–6.
Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695–703.
de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006; 96: 473–9.
Reference
Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? (Editorial). Can J Anesth 2007; 54: 689–95.
Author information
Authors and Affiliations
Additional information
Financial support: No financial support or funding.
Conflict of interest: Professor L.H.D.J. Booij is member of the Scientific Advisory Board, Organon NV, Oss, the Netherlands.
Rights and permissions
About this article
Cite this article
de Boer, H.D., Driessen, J.J., van Egmond, J. et al. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anesth 55, 124–126 (2008). https://doi.org/10.1007/BF03016324
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03016324